BAO PHARMA-B's stock soared 20.48% during intraday trading on Monday, driven by multiple positive developments.
The surge follows the company's announcement of its inclusion in the MSCI Global Small Cap Index, effective after the market close on May 29, 2026. This inclusion is expected to enhance the company's global visibility and attract passive fund inflows.
Additionally, the company disclosed that Chairman Dr. Liu Yanjun plans to increase his shareholding in the company, expressing confidence in its prospects. BAO PHARMA-B also intends to propose a share buyback mandate at its upcoming Annual General Meeting, authorizing the repurchase of up to 10% of its issued H shares.
Comments